research Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia
Finasteride is effective and safe for long-term treatment of hair loss in Japanese men.
Search
for
Sort by
Research
30 / 1000+ results
research Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
AGA linked to worse COVID-19 outcomes in men.
research Male balding is a major risk factor for severe COVID-19
Men with severe balding have a higher risk of getting very sick from COVID-19.
research Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.
research Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
research Clinical Analysis of 1,360 Patients Presenting with Male Pattern Hair Loss
Male pattern hair loss is diagnosed and treated earlier and is milder, possibly due to early puberty.
research Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men.
research 707 Hypoxia induced Multipotent Stem Cell-Secreted Proteins Induce Hair Growth in a Phase 1a/2b trial in Male Pattern Baldness
A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.
research 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY
Male pattern baldness may predict prostate cancer risk.
research 1465 骨材がコンクリートの乾燥収縮ひずみに及ぼす影響 : その1. 実験計画および実験結果(収縮・クリープ(5),材料施工)
Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men with AGA.
research Co-Relation Between Androgenetic Alopecia and Severity of COVID-19 Disease – A Cross-Sectional Study
Androgenetic alopecia may increase the severity of COVID-19.
research Hospitalized COVID-19 Androgenetic Alopecia JAAD data age group comparison with other references
Androgenetic alopecia may be linked to severe COVID-19.
research The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial
Minoxidil and pyrithione zinc combo most effectively increases hair density.
research O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation
Low-dose oral minoxidil and finasteride effectively improve hair growth in men with androgenetic alopecia.
research Evaluating the Role of the Gabrin Sign in Predicting COVID-19 Severity Among Patients with Androgenic Alopecia
Severe hair loss may increase the risk of dying from COVID-19.
research Raw data from JAAD research letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
Most severe COVID-19 patients had hair loss, suggesting a possible link.
research Cetuximab-induced hypertrichosis of the scalp and eyelashes
A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.
research Hair Transplantation
Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.
research Microstrip technique in follicular unit extraction
The microstrip technique for hair transplantation is effective and discreet for patients needing fewer than 1500 grafts.
research Minigraft Preparation in Surgical Hair Replacement
A new technique using a multibladed knife makes preparing hair transplant minigrafts faster and more uniform, leading to natural-looking results.
research A Clinical Study of Androgenic Alopecia (VII)
More men have Androgenic Alopecia than women, it's often inherited, and stress can contribute to it.
research 안드로겐 탈모증의 임상적 고찰(제7보)
More men have androgenic alopecia than women, with stress linked to the condition in both genders.
research Testosterone enantate
A man developed hair loss from testosterone treatment but improved with additional medication.
research Surgical reduction of alopecia
Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.
research Androgenetic Alopecia
Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.
research Reliability of the pattern hair loss classifications: A comparison of the basic and specific and N orwood–H amilton classifications
The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.
research Baldness, benign prostate hyperplasia, prostate cancer and androgen levels
The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.
research Male pattern androgenetic alopecia in an Indian context: a perspective study
At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.
research Classification of male-pattern hair loss
No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.
research Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany.
Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.